Jean-Paul Cheramy-Bien

Jean-Paul Cheramy-Bien

Auto-generated profile, based on publicly available information

Jean-Paul Cheramy-Bien

Department of Cardiovascular Surgery, CHU Liege, 4000 Liege, Belgium

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
PJPincemail Joël
Pincemail Joël
ECEtienne Cavalier
Etienne Cavalier
CCCorinne Charlier
Corinne Charlier
JCJean-Paul Cheramy–Bien
Jean-Paul Cheramy–Bien
EBEric Brevers
Eric Brevers
ARAnne-Françoise Rousseau
Anne-Françoise Rousseau
Background: A key role of oxidative stress has been highlighted in the pathogenesis of COVID-19. However, little has been said about oxidative stress status (OSS) of COVID-19 patients hospitalized in intensive care unit (ICU). Material and Methods: Biomarkers of the systemic OSS included antioxidants (9 assays), trace elements (3 assays), inflammation markers (4 assays) and oxidative damage to lipids (3 assays). Results: Blood samples were drawn after 9 (7–11) and 41 (39–43) days of ICU stay, respectively in 3 and 6 patients. Vitamin C, thiol proteins, reduced glutathione, γ-tocopherol, β-carotene and PAOT® score were significantly decreased compared to laboratory reference values. Selenium concentration was at the limit of the lower reference value. By contrast, the copper/zinc ratio (as a source of oxidative stress) was higher than reference values in 55% of patients while copper was significantly correlated with lipid peroxides (r = 0.95, p < 0.001). Inflammatory biomarkers (C-reactive protein and myeloperoxidase) were significantly increased when compared to normals. Conclusions: The systemic OSS was strongly altered in critically ill COVID-19 patients as evidenced by increased lipid peroxidation but also by deficits in some antioxidants (vitamin C, glutathione, thiol proteins) and trace elements (selenium).

1 May 2014 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
NSNatzi Sakalihasan
Natzi Sakalihasan
JDJean-Olivier Defraigne
Jean-Olivier Defraigne
MKMarie-Ange Kerstenne
Marie-Ange Kerstenne
JCJean-Paul Cheramy-Bien
Jean-Paul Cheramy-Bien
DSDiane T. Smelser
Diane T. Smelser
HKHelena Kuivaniemi
Helena Kuivaniemi

1 January 2011 in Journal of Nutrition and Metabolism
Verified
Journal Article
Open access
PDF file
PJpincemail Joël
pincemail Joël
SVSophie Vanbelle
Sophie Vanbelle
FDFabien Degrune
Fabien Degrune
JCJean-Paul Cheramy-Bien
Jean-Paul Cheramy-Bien
CCCorinne Charlier
Corinne Charlier
JDJean-Olivier Defraigne
Jean-Olivier Defraigne
Several factors, including fruit and vegetables intakes, have been shown to significantly influence the plasma concentrations of the two antioxidants vitamin C and β-carotene. Deficiency levels of 6 mg/L (34.2 μM) for vitamin C and of 0.22 mg/L (0.4 μM) for β-carotene have been suggested below which cardiovascular risk might be increased. The present study performed on 897 presumably healthy subjects aged 40–60 years aimed to examine how modifiable lifestyle factors may be related to vitamin C and/or β-carotene deficiency. Gender, smoking, lack of regular physical activity and of daily fruit consumption (≥2/day), and social status (in particular, unemployment) were found to be significant risk factors for vitamin C deficiency. For β-carotene deficiency, the same factors were identified except social status; moreover, overweight and OC use in women were also found to have a deleterious effect. For non exposed subjects, the probability of developing vitamin C deficiency was 4% in men and 2.4% in women. This probability increased to 66.3% for men and to 44.3% for women (and even to 50.4% under OC use), when all risk factors were present. For β-carotene deficiency, the corresponding probabilities were equal to 29.7% in men and 13.7% in women (no risk factor present), and to 86.1% for men and 69.9% (91.6% for OC use) for women (all factors present), respectively.

10 August 2018 in Current Drug Targets
Verified
Journal Article
Closed access
PDF file
JPJoël Pincemail
Joël Pincemail
JDJean-Olivier Defraigne
Jean-Olivier Defraigne
ACAudrey Courtois
Audrey Courtois
AAAdelin Albert
Adelin Albert
JCJean-Paul Cheramy-Bien
Jean-Paul Cheramy-Bien
NSNatzi Sakalihasan
Natzi Sakalihasan
Background: Abdominal aortic aneurysm (AAA) is a degenerative disease that causes mortality in people aged > 65 years. Increased reactive oxygen species (ROS) and oxidative stress seem to play a pivotal role in AAA pathogenesis. Several sources of ROS have been identified in aortic tissues using experimental models: inflammation, increased activity of NAD(P)H or NOX, over-expression of inducible nitric oxide synthase (iNOS), uncoupled endothelial nitric oxide synthase (eNOS), platelets activation and iron release from hemoglobin. Objectives: Human studies confirmed that oxidative stress and endothelial dysfunction, an important source of ROS production, were well associated with AAA development. Reducing oxidative stress by antioxidants can therefore be a good strategy for limiting AAA development. The objective of the present study is to review literature data favoring or not such a hypothesis. There is currently no evidence showing that strategies using classical low molecular weight antioxidants (vitamins C and E, β- carotene) as target for ROS is effective to reduce human AAA progression. However, recent epidemiological data have highlighted the positive role of a diet enriched in fruits which contain high amounts of antioxidant polyphenols. By their ability to restore endothelial function and also their capacity to stimulate enzymatic antioxidants through activation of the Keap1/Nrf2/ARE pathway, polyphenols can represent a promising treatment target for reducing human AAA progression. Conclusion: Clinical studies are therefore urgently necessary to confirm the potential beneficial effect of polyphenols in preventing or limiting AAA.

16 May 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
PJPincemail Joël
Pincemail Joël
VTVincent Tchana-Sato
Vincent Tchana-Sato
ACAudrey Courtois
Audrey Courtois
LMLucia Musumeci
Lucia Musumeci
JCJean-Paul Cheramy-Bien
Jean-Paul Cheramy-Bien
NSNatzi Sakalihasan
Natzi Sakalihasan
Background: Thoracic aortic dissection (TAD) is a life-threatening condition which usually occurs on an aneurysmal aortic wall. Although increasing data have shown that inflammation and oxidative stress play an important role in the patho-physiology of dissection, systemic oxidative stress status (OSS) has not been clearly determined in patients suffering from TAD. Methods: A cohort of 115 patients presenting type A or B TAD were admitted to our center from 2013 to 2017. Out of this cohort, 46 patients were included in a study on dissected aorta (LIege study on DIssected Aorta: LIDIA). In 18 out of the 46 patients, systemic OSS parameters were evaluated after TAD diagnosis by determination of eight different antioxidants, four trace elements, two markers of oxidative lipid damage and two inflammatory markers. Results: The 18 TAD patients included 10 men and 8 women (median age: 62 years; interquartile range: 55–68) diagnosed with type A (N = 8) or B (N = 10) TAD. Low plasma levels of vitamin C, β-carotene, γ-tocopherol, thiol proteins, paraoxonase and selenium were observed in these 18 patients. By contrast, the concentration of copper and total hydroperoxides, copper/zinc ratio, as well as inflammatory markers, were higher than the reference intervals. No difference was observed in oxidative stress biomarker concentrations between type A and B TAD patients. Conclusions: This pilot study, limited to 18 TAD patients, revealed a heightened systemic OSS, determined at 15.5 days (median) after the initial diagnosis, in those TAD patients without complications (malperfusion syndrome and aneurysm formation). Larger studies on biological fluids are needed to better characterize the oxidative stress and interpret its consequence in TAD disease.

27 May 2019 in Diseases
Verified
Journal Article
Open access
PDF file
PJPincemail Joël
Pincemail Joël
MKMessaouda KACI
Messaouda KACI
CJCheramy-Bien Jean-Paul
Cheramy-Bien Jean-Paul
JDJean Olivier Defraigne
Jean Olivier Defraigne
SMSmail Meziane
Smail Meziane
For the purpose of human disease prevention, several methods have been developed, and are still developing, to assess the oxidative stress status (OSS) of individuals. In the present paper, we describe an approach based on electrochemical detection able to evaluate skin oxidative stress status (SOSS) as a PAOT (Pouvoir AntiOxydant Total)-Skin Score®. Normal reference values for the PAOT-Skin Score® were: 0–62.94 (n = 263). Intra- and inter-assay coefficients of variation were, respectively, 12.47 ± 4.29% and 7.0 ± 2.5%. Our technology showed increased skin antioxidant activity following topical application of reduced coeznyme Q10 cream or vitamin C intake as orange juice or supplements. Moreover, we found significant correlations between some blood oxidative stress biomarkers and the PAOT-Skin Score® (γ-tocopherol/α-tocopherol ratio (r = 0.43, p = 0.020); copper (r = −0.42, p = 0.022); copper/zinc ratio (r = −0.49, p = 0.006), and lipid peroxides (r = −0.43, p = 0.002)). In addition to being non–invasive, the present electrochemical methodology is also not expensive, fast, and easy to use.